Core Insights - Two health-tech stocks are experiencing a significant surge in their Momentum scores, indicating strong performance relative to other stocks [1][2] Group 1: Sophia Genetics SA - Sophia Genetics SA's Momentum score increased from 32.45 to 81.80 over the past week [3] - The stock has surged by 30% in the past month due to an expanded collaboration with AstraZeneca PLC to develop an AI-powered next-generation sequencing solution for breast and prostate cancer [4] - The stock shows a favorable price trend across short, medium, and long-term time frames [4] Group 2: DarioHealth Corp - DarioHealth Corp's Momentum score rose from 7.69 to 59.45 within a week [5] - The stock has increased by over 83% in the past month, driven by the announcement of a committee exploring a potential sale, merger, or business combination [5] - Similar to Sophia Genetics, DarioHealth Corp also exhibits a favorable price trend in the short, medium, and long terms [6]